Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
2006 3
2007 1
2008 3
2009 1
2010 1
2011 4
2012 3
2013 5
2014 3
2015 6
2016 7
2017 2
2018 3
2019 3
2020 5
2021 11
2022 7
2023 8
2024 11
2025 14
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

88 results

Results by year

Filters applied: . Clear all
Page 1
A systematic review on type 3 diabetes: bridging the gap between metabolic dysfunction and Alzheimer's disease.
Atabi F, Moassesfar M, Nakhaie T, Bagherian M, Hosseinpour N, Hashemi M. Atabi F, et al. Diabetol Metab Syndr. 2025 Aug 27;17(1):356. doi: 10.1186/s13098-025-01930-2. Diabetol Metab Syndr. 2025. PMID: 40859375 Free PMC article. Review.
BACKGROUND: Alzheimer's disease (AD) is increasingly associated with metabolic dysfunction, particularly insulin resistance, which impairs neuronal signaling and energy metabolism. ...
BACKGROUND: Alzheimer's disease (AD) is increasingly associated with metabolic dysfunction, particularly insulin resistance, which im …
Resveratrol Augments Doxorubicin and Cisplatin Chemotherapy: A Novel Therapeutic Strategy.
Mirzaei S, Gholami MH, Zabolian A, Saleki H, Bagherian M, Torabi SM, Sharifzadeh SO, Hushmandi K, Fives KR, Khan H, Ashrafizadeh M, Zarrabi A, Bishayee A. Mirzaei S, et al. Curr Mol Pharmacol. 2023 Feb 23;16(3):280-306. doi: 10.2174/1874467215666220415131344. Curr Mol Pharmacol. 2023. PMID: 35430977 Review.
OBJECTIVE: The present review aims to give special attention to the therapeutic impacts of Res in potentiating DOX and CP's antitumor activities and reducing their side effects. METHODS: PubMed, Science Direct, and Google Scholar were used to search articles for the curren …
OBJECTIVE: The present review aims to give special attention to the therapeutic impacts of Res in potentiating DOX and CP's antitumor …
Regulation of Nuclear Factor-KappaB (NF-κB) signaling pathway by non-coding RNAs in cancer: Inhibiting or promoting carcinogenesis?
Mirzaei S, Zarrabi A, Hashemi F, Zabolian A, Saleki H, Ranjbar A, Seyed Saleh SH, Bagherian M, Sharifzadeh SO, Hushmandi K, Liskova A, Kubatka P, Makvandi P, Tergaonkar V, Kumar AP, Ashrafizadeh M, Sethi G. Mirzaei S, et al. Cancer Lett. 2021 Jul 1;509:63-80. doi: 10.1016/j.canlet.2021.03.025. Epub 2021 Apr 7. Cancer Lett. 2021. PMID: 33838282 Review.
Humoral and cellular response to the COVID-19 vaccine in immunocompromised children.
Morgans HA, Bradley T, Flebbe-Rehwaldt L, Selvarangan R, Bagherian A, Barnes AP, Bass J, Cooper AM, Fischer R, Kleiboeker S, Lee BR, LeMaster C, Markus K, Morrison S, Myers A, Myers D, Payne E, Schuster JE, Standley S, Wieser A, Warady B. Morgans HA, et al. Pediatr Res. 2023 Jul;94(1):200-205. doi: 10.1038/s41390-022-02374-4. Epub 2022 Nov 14. Pediatr Res. 2023. PMID: 36376507 Free PMC article.
Global burden of the COVID-19 associated patient-related delay in emergency healthcare: a panel of systematic review and meta-analyses.
Mogharab V, Ostovar M, Ruszkowski J, Hussain SZM, Shrestha R, Yaqoob U, Aryanpoor P, Nikkhoo AM, Heidari P, Jahromi AR, Rayatdoost E, Ali A, Javdani F, Farzaneh R, Ghanaatpisheh A, Habibzadeh SR, Foroughian M, Ahmadi SR, Akhavan R, Abbasi B, Shahi B, Hakemi A, Bolvardi E, Bagherian F, Motamed M, Boroujeni ST, Jamalnia S, Mangouri A, Paydar M, Mehrasa N, Shirali D, Sanmarchi F, Saeed A, Jafari NA, Babou A, Kalani N, Hatami N. Mogharab V, et al. Global Health. 2022 Jun 8;18(1):58. doi: 10.1186/s12992-022-00836-2. Global Health. 2022. PMID: 35676714 Free PMC article.
BACKGROUND: Apart from infecting a large number of people around the world and causing the death of many people, the COVID-19 pandemic seems to have changed the healthcare processes of other diseases by changing the allocation of health resources and changing people's acce …
BACKGROUND: Apart from infecting a large number of people around the world and causing the death of many people, the COVID-19 pandemic seems …
Gene Target Prediction of Environmental Chemicals Using Coupled Matrix-Matrix Completion.
Wang K, Kim N, Bagherian M, Li K, Chou E, Colacino JA, Dolinoy DC, Sartor MA. Wang K, et al. Environ Sci Technol. 2024 Apr 2;58(13):5889-5898. doi: 10.1021/acs.est.4c00458. Epub 2024 Mar 19. Environ Sci Technol. 2024. PMID: 38501580 Free PMC article.
Key to understanding chemical toxicity is knowledge of the molecular target(s) of the chemicals. Because a comprehensive safety assessment for all chemicals is infeasible due to limited resources, a robust computational method for discovering targets of environmental expos …
Key to understanding chemical toxicity is knowledge of the molecular target(s) of the chemicals. Because a comprehensive safety asses …
Pediatric Rome IV diagnosis agreement is greater than agreement on diagnostic testing.
Kaul I, Staggs VS, Bagherian A, Ali A, Shulman RJ, Colombo JM, Schurman JV, Chumpitazi BP, Friesen CA. Kaul I, et al. Neurogastroenterol Motil. 2022 Aug;34(8):e14355. doi: 10.1111/nmo.14355. Epub 2022 Mar 13. Neurogastroenterol Motil. 2022. PMID: 35279913
For each vignette, raters identified the most likely Rome IV diagnosis(es) and selected which diagnostic test(s) (if any) they typically would obtain. The survey was re-administered within 3 months. ...
For each vignette, raters identified the most likely Rome IV diagnosis(es) and selected which diagnostic test(s) (if any) they typica …
88 results